> ## Documentation Index
> Fetch the complete documentation index at: https://docs.getrivet.ca/llms.txt
> Use this file to discover all available pages before exploring further.

# The evidence base for measurement-based care

> Why MBC changes outcomes — what the research shows and what it means for your practice.

Measurement-based care is one of the few process changes in psychotherapy
with a sustained evidence base behind it. Practitioners who administer
validated outcome measures consistently — and who actually look at the
results between sessions — detect deterioration earlier and adjust treatment
sooner than practitioners who rely on impression alone.

## The Lambert program

Michael J. Lambert and colleagues at Brigham Young University ran the
foundational program of research on routine outcome monitoring. Across
multiple large clinical trials, they found that giving therapists a
session-by-session feedback signal about whether each client was on or off
the expected response trajectory:

* Reduced the rate of clients who deteriorated by the end of treatment
* Roughly doubled the rate of clinically significant improvement for clients
  who were predicted to be "not on track"
* Made the largest difference for the clients clinicians were most likely
  to miss on impression alone — the ones quietly drifting

Key references:

* Lambert, M. J., Whipple, J. L., & Kleinstäuber, M. (2018). "Collecting
  and delivering progress feedback: A meta-analysis of routine outcome
  monitoring." *Psychotherapy,* 55(4), 520–537.
* Lambert, M. J., et al. (2003). "Is it time for clinicians to routinely
  track patient outcome? A meta-analysis." *Clinical Psychology: Science
  and Practice,* 10(3), 288–301.

## Boswell and colleagues — why it doesn't always stick

James F. Boswell and colleagues have written extensively about why MBC
works clinically but doesn't always get adopted in real practices. Their
work identifies the practical barriers and what addresses them:

* Boswell, J. F., Kraus, D. R., Miller, S. D., & Lambert, M. J. (2015).
  "Implementing routine outcome monitoring in clinical practice: Benefits,
  challenges, and solutions." *Psychotherapy Research,* 25(1), 6–19.

Their conclusions, summarized:

* MBC works clinically. The evidence base is strong enough that it appears
  in APA, NICE, and SAMHSA guidance.
* The most common adoption failures are workflow failures, not clinical
  ones — long forms, async homework that doesn't come back, separate
  systems for measures and notes, no clear way to surface the result inside
  the session.
* The adoption pattern that does stick is the one where measures are
  administered consistently (intake, every 2–4 sessions, discharge) and
  the result is in front of the practitioner immediately.

## What this means for your practice

Three practical implications:

**Pick a small, consistent battery.** PHQ-9 for depression, GAD-7 for
anxiety, plus whatever specific measure fits the presenting concern
(PCL-5 for trauma, ISI for sleep, AUDIT for alcohol, K10 as a general
distress check). The benefit comes from administering the same measure
the same way, not from breadth.

**Administer at known intervals.** Intake. Every 2–4 sessions during
treatment. Discharge. This is the rhythm the research uses — and it's
the rhythm that catches non-response before it's entrenched.

**Look at the score during the session.** Not after. The conversation
about a worsening PHQ-9 is the intervention. A score sitting in a chart
folder until the following week is not the intervention.

## What the research does not say

A few honest limits on the literature:

* MBC doesn't replace clinical judgment. The score is one input among many.
* The size of the effect is modest at the level of the average client, and
  much larger for the subgroup who would otherwise deteriorate. The
  population benefit is concentrated in the clients you'd most want to
  catch early.
* Most of the trials use the OQ-45 or PCOMS (ORS/SRS) as the tracking
  measure. The PHQ-9 / GAD-7 / PCL-5 evidence is from outcome studies on
  the measures themselves rather than from MBC trials specifically — the
  generalization to those scales is reasonable but not identical.

## Related articles

<CardGroup cols={2}>
  <Card title="Administering measures in session" icon="clipboard-check" href="/measurement-based-care/administering-measures-in-session">
    The collaborative fill flow that puts the score in front of you while
    you can still talk about it.
  </Card>

  <Card title="Clinical change thresholds" icon="ruler" href="/measurement-based-care/clinical-change-thresholds">
    What counts as meaningful improvement on the measures you'll use most.
  </Card>
</CardGroup>
